Table 2.
Topic | Kappaa | 95% confidence interval | Percentage agreement |
---|---|---|---|
Purpose of visit | 0.63 | 0.37, 0.90 | 89 |
Prior knowledge about disease | 0.64 | 0.42, 0.86 | 85 |
Preference for information | 0.52 | 0.21, 0.83 | 86 |
Preference for decision-making role | 0.87 | 0.69, 1.0 | 95 |
Treatment recommendation | 0.60 | 0.38, 0.83 | 95 |
Impact of treatment on quality of life | 0.66 | 0.44, 0.89 | 97 |
Participation in recovery | 0.85 | 0.70. 1.0 | 99 |
Treatment goal | 0.60 | 0.38, 0.83 | 87 |
Qualitative prognostic information | 0.62 | 0.41, 0.84 | 91 |
Quantitative prognostic information | 0.74 | 0.56, 0.91 | 98 |
Hedging | 0.63 | 0.44, 0.81 | 97 |
Checks for understanding | 0.63 | 0.41, 0.85 | 82 |
Complementary/alternative medicine | 0.81 | 0.63, 0.98 | 91 |
Clinical trials | 0.86 | 0.67, 1.0 | 94 |
Cohen’s Kappa was used to calculate inter-rater reliability for each code using Landis and Kock’s classification (0.21–0.40, fair agreement; 0.41–0.60, moderate agreement; 0.61–0.80, substantial agreement; 0.81–1.0, near-perfect agreement) [31].